ARVN Q3 2018 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+102.2% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$14M-416.5% margin

Net Income

-$13M-396.6% margin

EPS (Diluted)

$-3.90

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$99M

Total Liabilities

$63M

Stockholders' Equity

$36M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+102.2%
Gross Profit	$3M	$2M	+102.2%
Operating Income	-$14M	-$6M	-119.3%
Net Income	-$13M	-$6M	-109.3%